vs
Side-by-side financial comparison of HEALTHY CHOICE WELLNESS CORP. (HCWC) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $18.7M, roughly 1.1× HEALTHY CHOICE WELLNESS CORP.). HEALTHY CHOICE WELLNESS CORP. runs the higher net margin — -8.9% vs -84.4%, a 75.5% gap on every dollar of revenue. HEALTHY CHOICE WELLNESS CORP. produced more free cash flow last quarter ($-927.1K vs $-39.7M).
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
HCWC vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.7M | $20.6M |
| Net Profit | $-1.7M | $-17.3M |
| Gross Margin | 39.1% | — |
| Operating Margin | -7.6% | -106.0% |
| Net Margin | -8.9% | -84.4% |
| Revenue YoY | — | -65.2% |
| Net Profit YoY | — | -173.8% |
| EPS (diluted) | $-0.05 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.7M | — | ||
| Q3 25 | $19.0M | — | ||
| Q2 25 | $20.2M | — | ||
| Q1 25 | $20.3M | $20.6M | ||
| Q4 24 | — | $37.4M | ||
| Q3 24 | $18.2M | $19.6M | ||
| Q2 24 | — | $94.7M | ||
| Q1 24 | — | $59.1M |
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-339.4K | — | ||
| Q1 25 | $-712.4K | $-17.3M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-2.7M | $-14.0M | ||
| Q2 24 | — | $55.0M | ||
| Q1 24 | — | $23.5M |
| Q4 25 | 39.1% | — | ||
| Q3 25 | 38.8% | — | ||
| Q2 25 | 40.1% | — | ||
| Q1 25 | 38.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 38.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -7.6% | — | ||
| Q3 25 | -3.2% | — | ||
| Q2 25 | -0.2% | — | ||
| Q1 25 | -2.0% | -106.0% | ||
| Q4 24 | — | -15.7% | ||
| Q3 24 | -2.0% | -110.7% | ||
| Q2 24 | — | 56.4% | ||
| Q1 24 | — | 35.7% |
| Q4 25 | -8.9% | — | ||
| Q3 25 | -6.4% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -3.5% | -84.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | -14.6% | -71.7% | ||
| Q2 24 | — | 58.1% | ||
| Q1 24 | — | 39.7% |
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.07 | $-0.42 | ||
| Q4 24 | — | $-0.20 | ||
| Q3 24 | $-0.29 | $-0.35 | ||
| Q2 24 | — | $1.55 | ||
| Q1 24 | — | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $67.8M |
| Total DebtLower is stronger | $7.3M | — |
| Stockholders' EquityBook value | $7.3M | $417.3M |
| Total Assets | $33.5M | $486.5M |
| Debt / EquityLower = less leverage | 1.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $4.7M | — | ||
| Q1 25 | $1.8M | $67.8M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | $1.8M | $78.0M | ||
| Q2 24 | — | $185.3M | ||
| Q1 24 | — | $68.4M |
| Q4 25 | $7.3M | — | ||
| Q3 25 | $8.5M | — | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $11.6M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $7.3M | — | ||
| Q3 25 | $5.9M | — | ||
| Q2 25 | $5.8M | — | ||
| Q1 25 | $2.1M | $417.3M | ||
| Q4 24 | — | $428.7M | ||
| Q3 24 | $2.9M | $422.4M | ||
| Q2 24 | — | $429.9M | ||
| Q1 24 | — | $269.4M |
| Q4 25 | $33.5M | — | ||
| Q3 25 | $33.7M | — | ||
| Q2 25 | $36.4M | — | ||
| Q1 25 | $34.1M | $486.5M | ||
| Q4 24 | — | $526.3M | ||
| Q3 24 | $33.2M | $554.6M | ||
| Q2 24 | — | $582.0M | ||
| Q1 24 | — | $510.8M |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 5.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.95× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-855.1K | $-38.5M |
| Free Cash FlowOCF − Capex | $-927.1K | $-39.7M |
| FCF MarginFCF / Revenue | -5.0% | -192.9% |
| Capex IntensityCapex / Revenue | 0.4% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $675.4K | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-855.1K | — | ||
| Q3 25 | $-308.7K | — | ||
| Q2 25 | $1.1M | — | ||
| Q1 25 | $1.1M | $-38.5M | ||
| Q4 24 | — | $-31.6M | ||
| Q3 24 | — | $-24.3M | ||
| Q2 24 | — | $39.8M | ||
| Q1 24 | — | $-25.5M |
| Q4 25 | $-927.1K | — | ||
| Q3 25 | $-351.3K | — | ||
| Q2 25 | $988.6K | — | ||
| Q1 25 | $965.3K | $-39.7M | ||
| Q4 24 | — | $-32.2M | ||
| Q3 24 | — | $-24.9M | ||
| Q2 24 | — | $38.8M | ||
| Q1 24 | — | $-26.4M |
| Q4 25 | -5.0% | — | ||
| Q3 25 | -1.8% | — | ||
| Q2 25 | 4.9% | — | ||
| Q1 25 | 4.8% | -192.9% | ||
| Q4 24 | — | -86.2% | ||
| Q3 24 | — | -127.3% | ||
| Q2 24 | — | 41.0% | ||
| Q1 24 | — | -44.6% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.6% | 5.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCWC
| Retail Grocery | $17.1M | 91% |
| Food Service Restaurant | $1.7M | 9% |
TRDA
Segment breakdown not available.
